NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Qureight

Qureight

Private
CambridgeHealthcare & Life Scienceshttps://www.qureight.com/

Last Round

Series A

Apr 16, 2024

Total Funding Raised

$11.23M

Company Overview

Qureight is a biotechnology company that provides an AI-powered clinical data curation and analytics platform to accelerate drug development for lung and heart diseases.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

medical imagingclinical trialsimaging CROmedical AIhealthcare analyticscontract research organizationCROdigital biomarkersquantitative imagingsynthetic control armsDICOMAI-driven diagnosticsradiomicsdrug developmentSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qureight Comparables

Compare Qureight with similar companies based on industry and business-model similarity.

Qureight comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QMENTA
84%
Flywheel
80%
Banook
78%

Qureight Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 16, 2024
SeedFeb 3, 2022
SeedSep 24, 2021

Key People

Founding team and executive leadership

Muhunthan Thillai

Co-Founder And CEO

Founding Team

Patrick Driscoll

Chief Financial Officer

Executive Team

Qureight Investors

Notable investors and investment history

Qureight investors
InvestorRounds
Ascension VenturesSeries A, Seed
Playfair CapitalSeries A, Seed
Canaccord Genuity Wealth ManagementSeries A
Cambridge AngelsSeries A, Seed
Meltwind AdvisorySeries A, Seed
CMS VenturesSeries A, Seed
Hargreave Hale AIM VCTSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 12, 2026

    Rebecca Simmons appointed as the new COO.

  • Jan 7, 2026

    Dr. Steven Bishop appointed as the new Chief Medical Officer.

Qureight Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qureight Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qureight's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range53
Year Founded2018
Last FundingApr 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.